Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jaime Díaz-Guzmán"'
Autor:
Macarena Hernández-Jiménez, Carolina Peña-Martínez, María Del Carmen Godino, Jaime Díaz-Guzmán, María Ángeles Moro, Ignacio Lizasoain
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176770 (2017)
Stroke is a cerebrovascular pathology for which the only approved treatment is fibrinolysis. Several studies have focused on the development of new drugs but none has led to effective therapies to date, due, among others, to the difficulty to evaluat
Externí odkaz:
https://doaj.org/article/86bdd5fcdc2b418582dd199d3e71df96
Autor:
Aleix Llorac, Inmaculada Roldán-Rabadán, Pablo Rebollo, Mar Genís-Gironés, Jaime Díaz-Guzmán, Román Freixa-Pamias, Beatriz Antolin-Fontes, Carlos Escobar-Cervantes, Javier García-Alegría, Alejandro-Isidoro Pérez Cabeza
Publikováno v:
Revista Española de Cardiología. 75:496-505
Resumen Introduccion y objetivos La prevalencia y la incidencia de la fibrilacion auricular (FA), un importante factor de riesgo de ictus cardioembolico, han aumentado sustancialmente en los ultimos anos. Sin embargo, varios estudios europeos han obs
Autor:
Irene Hidalgo Mayoral, Antonio Martínez-Salio, Sara Llamas-Velasco, Irene Gómez-Majón, Ana Arteche-López, Juan Francisco Quesada-Espinosa, Carmen Palma Milla, Jose Miguel Lezana Rosales, Rubén Pérez de la Fuente, Alexandra Juárez Rufián, Olalla Sierra Tomillo, Maria Teresa Sánchez Calvín, Maria José Gómez Rodríguez, Patricia Ramos Gómez, Alberto Villarejo-Galende, Jaime Díaz-Guzmán, Maria Ángeles Ortega-Casarrubios, Patricia Calleja-Castaño, Marta Moreno-García
Publikováno v:
European journal of medical genetics. 65(8)
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is an autosomal recessive vascular disorder caused by biallellic variants in HTRA1. Recently, it has been reported that several heterozygous mutatio
Autor:
C. Alonso-Ortiz del Rio, M. Barcos Martínez, E. Calderón Sandubete, Manuel Posada de la Paz, Pilar Giraldo Castellano, R. Santamaría Olmo, Juan Ramón Gimeno Blanes, José María Carrión Pérez, Alberto Ortiz Arduan, E. Briones Pérez de la Blanca, Encarnación Guillén Navarro, Paz Latre Martínez, Ignacio Marin-Leon, Mónica López Rodríguez, M. López Mendoza, Jordi Cruz Villalba, Jaime Díaz Guzmán, C. Márquez Infante
Publikováno v:
Revista Clínica Española (English Edition). 219:200-207
Anderson–Fabry disease is a severe progressive multisystem condition of genetic origin that affects men and women, reducing their life expectancy and quality of life. The considerable variability in its clinical expression, the difficulties in diag
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 27:3652-3656
Background Both acute single intracranial and tandem occlusions are managed with intravascular thrombectomy with success, but little evidence exists about the differences in their mid-term outcome. We aim to compare the outcome at 3 months after tand
Autor:
Aleix Llorac, Pablo Rebollo, Mar Genís-Gironés, Román Freixa-Pamias, Carlos Escobar-Cervantes, Javier García-Alegría, Beatriz Antolin-Fontes, Inmaculada Roldán-Rabadán, Jaime Díaz-Guzmán, Alejandro-Isidoro Pérez Cabeza
Publikováno v:
Revista espanola de cardiologia (English ed.). 75(6)
Introduction and objectives The incidence and prevalence of atrial fibrillation (AF), a major risk factor for stroke, has increased substantially in the past few years. However, several studies have reported a decline in AF-related stroke rates assoc
Autor:
Carlos Avendaño, David Fernández-López, María A. Moro, Mar Castellanos, Carolina Peña-Martínez, Isaac García-Yébenes, Teresa Gasull, Jaime Díaz-Guzmán, Ignacio Lizasoain, Pilar Negredo, Antoni Dávalos, Alicia García-Culebras
Publikováno v:
Stroke
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background and Purpose— Recanalization with tPA (tissue-type plasminogen activator) is the only pharmacological therapy available for patients with ischemic stroke. However, the percentage of patients who may receive this therapy is limited by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7868ed0195a8ca8b93cbf3bd847da5d6
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5495
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5495
Autor:
Alicia García-Culebras, Jaime Díaz-Guzmán, Ignacio Lizasoain, Violeta Durán-Laforet, Iván Ballesteros, María A. Moro, Jesús M. Pradillo, Carolina Peña-Martínez
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Ischemic brain injury causes a local inflammatory response, involving the activation of resident brain cells such as microglia and the recruitment of infiltrating immune cells. Increasing evidence supports that plasticity of the myeloid cell lineage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b0eb1ff02ef247f2cf1ad843c67f232
https://saludmadrid.ibai.com/handle/20.500.12530/35782
https://saludmadrid.ibai.com/handle/20.500.12530/35782
Autor:
Ferrán Catalá-López, Consuelo Morant-Ginestar, Elena Álvarez-Martín, Jaime Díaz-Guzmán, Ricard Gènova-Maleras, Nerea Fernández de Larrea-Baz
Publikováno v:
Medicina Clínica. 144:353-359
Background and objective The aim of the present study was to determine the national burden of cerebrovascular diseases in the adult population of Spain. Patients and methods Cross-sectional, descriptive population-based study. We calculated the disab
Autor:
Silvia Vazquez Fernandez del Pozo, Felix Bermejo Pareja, Jaime Díaz Guzmán, Agustín Gómez de la Cámara, Agustin Rivero dCuadrado, Jose Felipe Varona Arche, Paloma Ferrando dVivas
Publikováno v:
Research in Neurology: An International Journal. :1-13
Background: Cumulative risk of stroke recurrence is about 26% at five years, with overall mortality rate of 38%. Objective: to develop a user-friendly clinical prediction algorithm of ischemic stroke recurrence to help in the design of long-term stra